Soft Tissue Sarcoma of the Extremity Comparison of Conformal Post-operative Radiotherapy (IMRT)
Download
Report
Transcript Soft Tissue Sarcoma of the Extremity Comparison of Conformal Post-operative Radiotherapy (IMRT)
CTOS 14.11.08
Soft Tissue Sarcoma of the Extremity
Comparison of Conformal Post-operative
Radiotherapy (CRT) and Intensity Modulated
Radiotherapy (IMRT)
Young K Lee1, Alexandra J Stewart2, Frank H Saran3
1Joint
Department of Physics, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK
2St Luke’s Cancer Centre, Royal Surrey County Hospital, Guildford, Surrey, UK
3Department of Radiotherapy, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK
CRT and IMRT for extremity STS
Background
Materials and Methods
Results
Summary
CRT and IMRT for extremity STS
Background
Materials and Methods
Results
Summary
Background
Limb-sparing surgery in combination with focal
radiotherapy - standard of care in patients with
intermediate and high grade limb and limb girdle
soft tissue sarcomas (STS)
Normal tissue toxicity increases with escalating
total and integral dose
Dose prescription limited by organs-at-risk (OAR)
surrounding the PTV
Aims
To define a reproducible and comparable target
volume definition for CT planning
To define reproducible prospective planning dose
volume constraints
To assess the ability of inversely-planned IMRT
plans to minimise the dose to surrounding OAR
To assess efficacy of ‘simple’ IMRT compared to
‘complex’ IMRT planning
CRT and IMRT for extremity STS
Background
Materials and Methods
Results
Summary
Patient data
T2 and G2/3 STS of the thigh (n=10)
No tumours invading bone
Entire surgical scar and all drain sites marked
Planning CT scan (GE HiSpeed QX/i, Milwaukee, WI)
• pelvic brim to below knee
• customised immobilisation
• slice thickness = 2.5mm
Target volume definition
Phase I volume
PTV1 = tumour bed + 5cm SI and 3cm
circumferentially
Phase II volume
PTV2 = tumour bed + 2cm isotropically
OAR defined as whole femur, neurovascular
bundle, normal tissue corridor and normal tissue
outside PTV1
Planning target volumes
PTV1
PTV2
Organ definition
neurovascular bundle
PTV2
PTV1
whole femur
normal tissue
outside PTV1
tissue corridor
Radiotherapy planning
Primary planning objective
• PTV dose
• femur
• skin corridor
Other planning objectives
• neurovascular bundle
• soft tissue outside PTV
Dose prescription
Pinnacle3 v7.4f (Philips Radiation Oncology
Systems, Madison, WI)
2-phase 3D-CRT
• Ph I - 50 Gy/25# (5 weeks)
• Ph II - 16 Gy/8# (1½ weeks)
IMRT with simultaneous integrated boost (SIB)
• Ph I - 50 Gy/25# (5 weeks)
• Ph II - 62.5 Gy/25# (5 weeks) (/ = 10 Gy)
Analysis
cumulative dose volume histograms (DVH)
Dmean, Dmax, Dmin
Conformity Index (CI)
Heterogeneity Index (HI)
CRT and IMRT for extremity STS
Background
Materials and Methods
Results
Summary
Conformal
2-34-5
field
(simple)
Radiotherapy
field
IMRT IMRT
sagittal view
conformal
2-3f
4-5f IMRT
coronal view
conformal
2-3f IMRT
4-5f IMRT
Conformity and Heterogeneity
3DCRT
Mean
Conformity p-value
Index (range)
1.76
(1.48-2.47)
2/3f
IMRT
1.59
(1.15-2.67)
0.02
4/5f
IMRT
1.33
(1.08-1.84)
0.0002
Mean
Heterogeneity p-value
Index (range)
1.052
(1.031-1.065)
1.045
(1.029-1.063)
0.06
1.036
(1.027-1.049)
0.001
DVH summary
‘Simple’ 2-3f IMRT?
Median number of segments
• 26 (range 13-37) for 2-3f IMRT
• 36 (range 34-56) for 4-5f IMRT
Both IMRT plans were more conformal and less
heterogeneous than 3D-CRT
Both IMRT delivered significantly lower femur V45
compared to 3D-CRT plans
HOWEVER, 4/5f IMRT resulted in significantly
lower femur V45 when compared directly to 2/3f
IMRT (p=0.04)
CRT and IMRT for extremity STS
Background
Materials and Methods
Results
Summary
Summary
Reproducible, comprehensive planning guidelines
and dose-volume constraints for 3D planning for
extremity sarcomas devised
4/5f IMRT plan - lowest clinically relevant doses to
OAR whilst delivering conformal doses to PTV
Large primary tumour
• 4/5f preferable to a 2/3f IMRT approach
Small, superficial disease
• 3D-CRT may provide adequate
added cost and complexity
treatment
without
Further work
Results from this study may not be directly
translated to all other primary locations of STS of
the extremity
IMRT approach should be assessed prospectively
with respect to late toxicity within the confines of
a prospective clinical trial
Acknowledgment
Radiotherapy Department
Royal Marsden NHS Foundation Trust